Stonkpile/xStocks/no 24/7 oracle
Eli Lilly rates C Thin.
50 out of 100 for the market around LLYx: $14k you can sell into, $17k of volume in a day, 1 pool and a perp on Phoenix and Hyperliquid. It rates the market, never the company.
LLYx contractcheck it on Solscan
LLYx rates C50 Thin
Each part is scored out of 10 and carries its own weight, so ten across all four is exactly 100. Nothing here is about the company, or about whether the price is fair.
- Liquidity1.4/10 ×4$14k in the pool
- Real volume10.0/10 ×2.5turns over 1.2x its own size a day
- Pools & perps6.0/10 ×2one venue, 2 perp markets
- Pricing4.7/10 ×1.5no price after the closing bell, another issuer agrees within 1%
A tracker certificate giving economic exposure, with no shareholder rights. Dividends on the underlying are reinvested into more of the same token rather than paid out.
Redeemable directly with the issuer, retail included, subject to KYC and a $5,000 minimum. Not offered in the United States.
Read 2026-10-04 from xStocks documentation and Kraken's risk disclosure. source and a second. Terms change, so check them before you act on this.
- One pool. If it empties, the exit empties with it.
- No reference price once the US market shuts.
Is LLYx what it says it is?
Five arithmetic checks on the tokenized stock itself, before you look at anything quoted against it.
Metadata is served from xStocks's own domain, which is how this index separates real tokenized stocks from the hundreds of lookalikes that simply put the name in their title.
Very thin. Expect significant slippage on anything but small orders.
Pyth only publishes LLY during the US session. Once the closing bell goes there is no independent reference price, and that is when on-chain quotes drift furthest from fair value.
A single pool. If it is pulled, there is nowhere else to exit.
Modest holder base for a tokenized equity.
These are arithmetic checks on public data, not advice. They tell you what the numbers look like, not what to do about them.